Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Jan. 31, 2013	Jan. 31, 2012
Net income	$ 23,376,000	$ 23,346,000
Adjustments to reconcile net income from operations to net cash used in operating activities:
Provision for credit losses	70,499,000	62,056,000
Losses on claims for payment protection plan	5,249,000	4,353,000
Depreciation and amortization	2,070,000	1,697,000
Amortization of debt issuance costs	155,000	133,000
Loss on sale of property and equipment	64,000	15,000
Stock based compensation	1,525,000	1,681,000
Deferred income taxes	1,784,000	3,061,000
Change in operating assets and liabilities:
Finance receivable originations	(284,931,000)	(263,539,000)
Finance receivable collections	144,025,000	140,084,000
Accrued interest on finance receivables	(506,000)	(444,000)
Inventory	19,283,000	19,470,000
Prepaid expenses and other assets	(642,000)	630,000
Accounts payable and accrued liabilities	2,806,000	(547,000)
Deferred payment protection plan revenue	1,614,000	1,169,000
Income taxes, net	(463,000)	1,052,000
Excess tax benefit from share based compensation	(99,000)	(197,000)
Net cash used in operating activities	(14,191,000)	(5,980,000)
Investing Activities:
Purchase of property and equipment	(3,438,000)	(3,228,000)
Proceeds from sale of property and equipment	199,000
Net cash used in investing activities	(3,239,000)	(3,228,000)
Financing Activities:
Exercise of stock options and warrants	665,000	1,355,000
Excess tax benefit from share based compensation	98,000	197,000
Issuance of common stock	143,000	118,000
Purchase of common stock	(17,248,000)	(29,950,000)
Dividend payments	(30,000)	(30,000)
Debt issuance costs	(56,000)
Change in cash overdrafts	3,017,000	1,370,000
Proceeds from revolving credit facilities	238,336,000	236,980,000
Payments on revolving credit facilities	(206,906,000)	(200,646,000)
Net cash provided by financing activities	18,019,000	9,394,000
Increase in cash and cash equivalents	589,000	186,000
Cash and cash equivalents, beginning of period	276,000	223,000
Cash and cash equivalents, end of period	$ 865,000	$ 409,000